Mavericks guard Dante Exum underwent surgery on Tuesday to address a right wrist injury, the team announced in a press release. Reporting last week indicated that Exum had suffered a “serious” wrist injury and that surgery was one of the treatment options being considered.
While the Mavs’ announcement didn’t include an estimated recovery timeline, Shams Charania of ESPN (Twitter link) reports that Exum is expected to be sidelined for the next three months. That would put him in line for a return sometime in the new year.
Exum, 29, was the fifth overall pick in the 2014 draft, but battled health issues early in his NBA career and struggled to develop into a reliable rotation piece. He spent two seasons overseas from 2021-23 and played well for FC Barcelona in Spain and KK Partizan in Serbia, earning another shot in the NBA.
The 6’5″ guard signed a two-year contract with the Mavericks during the 2023 offseason and played a regular role for the Western Conference champions last season, averaging 7.8 PPG and 2.9 APG with a .533/.491/.779 shooting line and strong defense in 55 games (19.8 MPG).
Once again though, injuries have been an obstacle since his return stateside. Exum missed time last season due to foot and knee ailments, then had to sit out Australia’s first game at the Paris Olympics in July due to a compound dislocation of his right index finger. Now he’s expected to be on the shelf for roughly half of the 2024/25 regular season.
With Exum unavailable this fall, the Mavericks figure to lean more heavily on veteran guard Spencer Dinwiddie and third-year pro Jaden Hardy for backcourt depth behind superstars Luka Doncic and Kyrie Irving.